5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B. J.; Finley, D.; Azzoli, C. G.; Riely, G. J.; Rusch, V. W.; Kris, M. G.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Molecular biology of prostate cancer
    Book Section

    Chen, Y.; Sawyers, C. L.
    In DeVita, V. T.; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th ed (2008)

    Fulltext@MSK | Save
  • Evidence for an androgen receptor threshold dependency in prostate cancer cells with natural androgen receptor overexpression
    Meeting Abstract

    Watson, P. A.; Wongvipat, J.; Leung, D. H.; Sawyers, C. L.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Neutrophils but not alveolar macrophages are essential at early time points following aspergillus infection
    Meeting Abstract

    Mircescu, M. M.; Lipuma, L.; Pamer, E. G.; Hohl, T. M.
    Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (2008)

    Fulltext@MSK | Save
  • PLX4032, a selective inhibitor of RAF kinase activity, inhibits BRAF(V600E) tumor proliferation and MAPK signaling in vitro and in vivo
    Meeting Abstract

    Joseph, E. W.; Poulikakos, P. I.; Pratilas, C. A.; Halilovic, E.; Lobo, J. M.; Bollag, G.; Tsai, J.; Solit, D. B.; Rosen, N.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Coexistent PI3K mutation in human tumors is associated with decreased dependency on mutant KRAS and MEK/ERK signaling for transformation
    Meeting Abstract

    Halilovic, E.; She, Q.; Ye, Q.; Solit, D. B.; Rosen, N.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Stimulation of epidermal growth factor (EGFR) or HER-3 mediates resistance to MET tyrosine kinase inhibition in MET-amplified gastric cancer cells
    Meeting Abstract

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. L.; Tang, L.; Song, L.; Zeng, Z.; Shah, M.; Christensen, J. G.; Rosen, N.; Solit, D. B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Integrative analysis of genomic aberration and gene expression suggests that MPD with loss of heterozygosity or gain of chromosome 9 represents a distinct entity
    Meeting Abstract

    Zhang, W. J.; Ebert, B. L.; Berkofsky-Fessler, W.; Buzzai, M.; Sun, Y. Z.; Xi, C. X.; Levine, R. L.; Gilliland, G.; Licht, J. D.
    Blood (2008)

    Fulltext@MSK | Save
  • Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T-cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Gastric carcinomas with lymphoid stroma show distinct molecular features that reflect their Epstein-Barr virus (EBV) and microsatellite instability (MSI) status
    Meeting Abstract

    Young, G. Q.; Shia, J.; Tang, L. H.; Klimstra, D. S.; Chen, Y.; Yantiss, R. K.
    Laboratory Investigation (2008)

    Fulltext@MSK | Save